RATIONALE: Gathering information about metabolic syndrome from young patients who have survived acute lymphoblastic leukemia (ALL) may help doctors learn more about the disease. PURPOSE: This phase I trial is studying the metabolic syndrome in young patients who have survived acute lymphoblastic leukemia and in healthy sibling volunteers.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Prevalence of the metabolic syndrome (MS) and its component traits in these patients and in healthy volunteers
Timeframe: 2009-2011
Host- and treatment-related risk factors for MS
Timeframe: 2009-2011